- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2013
- Public Summary Document (PSD) March 2013 PBAC Meeting - PDF
Dabigatran etexilate – March 2013
Dabigatran etexilate, capsules, 110 mg and 150 mg (as mesilate), Pradaxa®
Last updated
8 November 2023